JOURNAL OF CLINICAL APHERESIS
Scope & Guideline
Pioneering Research in Apheresis for Enhanced Clinical Practices
Introduction
Aims and Scopes
- Therapeutic Apheresis Techniques:
The journal highlights various therapeutic apheresis methods, including therapeutic plasma exchange, leukapheresis, and immunoadsorption, focusing on their clinical applications for conditions such as autoimmune diseases, hematologic disorders, and organ transplant management. - Clinical Outcomes and Efficacy:
Research articles often evaluate the efficacy, safety, and clinical outcomes associated with different apheresis procedures, providing evidence-based insights that guide clinical practice and improve patient care. - Innovations in Apheresis Technology:
The journal explores advancements in apheresis technology, including new devices and techniques that enhance the efficiency and safety of procedures, thus contributing to the evolution of apheresis in clinical settings. - Patient-Centered Care:
Emphasis is placed on understanding patient experiences, tolerability, and outcomes related to apheresis treatments, aiming to improve the overall quality of care for patients undergoing these procedures. - Interdisciplinary Collaboration:
The journal promotes interdisciplinary research and collaboration among clinicians, researchers, and technologists in the field of apheresis, recognizing the importance of diverse perspectives in advancing the field.
Trending and Emerging
- COVID-19 Related Apheresis Applications:
Recent publications increasingly focus on the use of therapeutic apheresis in managing complications related to COVID-19, including the treatment of cytokine storms and the effectiveness of convalescent plasma therapy. - Personalized Apheresis Approaches:
There is a growing trend towards personalized apheresis approaches tailored to individual patient profiles, including genetic and immunological factors, enhancing the efficacy and safety of treatments. - Pediatric Apheresis Innovations:
An increasing number of studies are dedicated to pediatric apheresis, addressing unique challenges and innovations in performing apheresis in younger populations, which is crucial for optimizing care in this vulnerable group. - Integration of Apheresis with Other Therapies:
Emerging research explores the integration of apheresis with other therapeutic modalities, such as immunotherapy and targeted therapies, to enhance treatment outcomes for complex conditions. - Long-Term Outcomes and Quality of Life Studies:
There is a rising emphasis on studies that assess long-term outcomes and quality of life for patients undergoing apheresis, reflecting a broader focus on holistic patient care and post-treatment follow-up.
Declining or Waning
- Traditional Hemapheresis Techniques:
There has been a noticeable decline in studies focused on traditional hemapheresis methods, as newer technologies and techniques gain prominence in clinical practice, leading to reduced interest in established methods. - Generalized Apheresis Protocols:
The publication of generic apheresis protocols without specific clinical context or outcomes has decreased, suggesting a shift towards more tailored and condition-specific research. - Single-Center Studies:
There appears to be a waning emphasis on single-center studies, with a preference for multicenter collaborations that provide more robust data and insights applicable across diverse clinical settings. - Basic Research on Apheresis Mechanisms:
Research focusing solely on the basic mechanisms of apheresis without direct clinical application or implications is less frequently published, as the journal prioritizes studies that demonstrate clear clinical relevance.
Similar Journals
Physioscience
Shaping the future of rehabilitation sciences together.Physioscience is a premier academic journal dedicated to the evolving field of physiotherapy and rehabilitation sciences, published by the esteemed GEORG THIEME VERLAG KG. The journal serves as a crucial platform for researchers, clinicians, and practitioners to disseminate cutting-edge research, innovative practices, and comprehensive reviews aimed at enhancing patient care and advancing the knowledge base in physical therapy. Although Physioscience does not operate under an open access model, it ensures wide visibility and accessibility of scholarly articles through esteemed databases. Its rigorous peer-review process guarantees the highest quality of published content, thereby maintaining its reputation as a leading resource for both fundamental research and clinical applications in physiotherapy. Positioned significantly in the health sciences field, Physioscience strives to foster interdisciplinary collaboration and stimulate ongoing dialogue among healthcare professionals, ultimately aiming to inform best practices and improve clinical outcomes worldwide.
Female Pelvic Medicine and Reconstructive Surgery
Fostering excellence in women's health practices.Female Pelvic Medicine and Reconstructive Surgery is a prestigious journal that focuses on the intricate and evolving fields of urogynecology and pelvic floor disorders. Published by LIPPINCOTT WILLIAMS & WILKINS, this journal aims to disseminate high-quality research, clinical practice guidelines, and educational content that addresses the challenges faced by practitioners in medicine, obstetrics, gynecology, and urology. Though its coverage in Scopus has been discontinued, it continues to play a vital role in influencing current practices evidenced by its ranking in the 52nd percentile for Surgery, 44th for Obstetrics and Gynecology, and 41st for Urology, showcasing the journal's relevance in the medical community. With an engaging format and open-access options, it provides an invaluable resource for researchers, clinicians, and students alike, facilitating advancements in understanding and treating pelvic floor conditions. The journal serves as a critical platform for sharing innovative ideas and research findings that improve patient care and enhance healthcare outcomes in women's health.
Therapeutic Advances in Psychopharmacology
Leading the Charge in Mental Health InnovationsTherapeutic Advances in Psychopharmacology is a leading open-access journal published by SAGE Publications Ltd, focusing on the dynamic integration of pharmacological therapies and psychological health. Since its inception in 2011, this journal has made a significant impact on the fields of pharmacology and psychiatry, consistently earning a Q1 ranking in both categories as of 2023, reflecting its esteemed position within the scientific community. With an impressive Scopus rank placing it in the top 15% across relevant disciplines, the journal serves as a vital platform for researchers, professionals, and students eager to explore cutting-edge advancements in psychopharmacology. The open-access model, established in 2019, ensures that groundbreaking research is accessible to a wide audience, fostering collaboration and innovation in therapeutic strategies for mental health disorders. Through the dissemination of high-quality research and reviews, Therapeutic Advances in Psychopharmacology is committed to advancing understanding and practice within this critical field.
Indian Journal of Respiratory Care
Advancing Respiratory Health Through Open Access ResearchWelcome to the Indian Journal of Respiratory Care, a premier platform dedicated to advancing research and clinical practices in the field of respiratory health. Published by JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD, this journal has established itself as a crucial resource for researchers, healthcare professionals, and educators since embracing an Open Access model in 2012, ensuring maximum visibility and accessibility of vital research findings. The journal aims to disseminate high-quality articles encompassing a wide range of topics, including but not limited to, respiratory diseases, pulmonary care, and innovative treatment approaches. With its commitment to fostering collaboration and knowledge exchange, the Indian Journal of Respiratory Care is poised to make a significant impact in the ever-evolving landscape of respiratory medicine. As the field continues to grow, this journal serves as an essential touchpoint for those invested in enhancing patient care and outcomes.
RHEUMATOLOGY INTERNATIONAL
Pioneering breakthroughs in therapeutic interventions.Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.
Plasmatology
Transforming Hematology Through Innovative StudiesPlasmatology, published by SAGE Publications Ltd, is a pioneering open-access journal devoted to the field of hematology, focusing on the latest advancements and research in plasma science and its applications. Established in 2021, this journal aims to foster knowledge exchange among researchers, practitioners, and students by providing a platform for sharing innovative studies and reviews. While currently positioned in the Q4 quartile for hematology and ranking #111 in the Scopus database, Plasmatology is dedicated to enhancing its influence and reflecting the dynamic nature of hematological research. With access options freely available to all, the journal encourages a collaborative approach to address the challenges and developments in the field. Based in the United Kingdom, Plasmatology is an emerging resource for anyone interested in advancing their understanding and involvement in plasma research.
Lancet Haematology
Fostering excellence in hematological research and practice.Lancet Haematology, published by Elsevier Science Ltd in the United Kingdom, is a premier peer-reviewed journal dedicated to advancing the field of hematology. With an impressive impact factor and listed in the Q1 category in hematology for 2023, this journal ranks #4 out of 137 in the Scopus database, boasting a 97th percentile indicating its influential role in disseminating high-quality research. Since its establishment in 2014, Lancet Haematology has provided a vital platform for researchers and clinicians to share groundbreaking studies, innovative treatment approaches, and novel therapeutic discoveries relevant to various hematological disorders. The journal does not operate under an open access model, but it offers multiple access options to facilitate engagement with its content. By bridging clinical practice and cutting-edge research, Lancet Haematology aims to foster the advancement of knowledge and improve patient outcomes in hematology, making it an essential read for professionals, researchers, and students alike.
TRANSFUSION AND APHERESIS SCIENCE
Innovating Patient Care Through Apheresis and Transfusion InsightsTRANSFUSION AND APHERESIS SCIENCE, published by Pergamon-Elsevier Science Ltd, serves as a pivotal platform for researchers and practitioners in the fields of hematology, transfusion medicine, and apheresis. With an ISSN of 1473-0502 and an E-ISSN of 1878-1683, this peer-reviewed journal boasts a respectable Q3 ranking in the Hematology category as of 2023, positioning it within the 45th percentile among its counterparts. Operating from the United Kingdom, it provides comprehensive insights into the latest advancements and methodologies in transfusion practices and apheresis technology, crucial for enhancing patient care and therapeutic strategies. The journal's scope, covering key developments from 1996 to 2024, allows for a deep exploration of historical and emerging trends within the discipline. Moreover, its open access options facilitate widespread dissemination of research findings, fostering collaboration and innovation in the scientific community. For those dedicated to advancing knowledge in hematology, TRANSFUSION AND APHERESIS SCIENCE represents an essential resource, bridging theory and practice in this vital area of healthcare.
International Journal of Laboratory Hematology
Connecting research and practice for the future of laboratory hematology.The International Journal of Laboratory Hematology, published by WILEY, serves as a vital resource in the field of hematology, delivering high-quality research findings and innovations within laboratory practices since its inception in 2007. This journal, accessible under Open Access options, showcases cutting-edge studies that span critical aspects of biochemistry and clinical laboratory methodologies. With a notable impact factor reflected in its Q2 and Q3 rankings across various categories—such as Biochemistry (medical) and Hematology—this journal stands out within the Scopus rankings, positioning itself within the 60th and 59th percentiles of its respective fields. Situated in the United Kingdom, the journal's objectives lie in disseminating pivotal research that enhances our understanding of hematological disorders and laboratory techniques, making it an essential tool for researchers, professionals, and students alike who are committed to advancing the science of laboratory hematology and its applications.
Iraqi Journal of Hematology
Elevating Knowledge, Elevating CareIraqi Journal of Hematology is a prominent peer-reviewed open-access journal dedicated to advancing the field of hematology. Published by Wolters Kluwer Medknow Publications, this journal provides a platform for researchers, professionals, and students to share cutting-edge findings and developments in various aspects of hematology, including blood diseases, diagnostics, and innovative treatments. Since its transition to open access in 2016, the journal has significantly increased its reach, allowing for wider dissemination of critical research to a global audience. With an ISSN of 2072-8069 and an E-ISSN of 2543-2702, the Iraqi Journal of Hematology strives to adhere to the highest scholarly standards and plays a vital role in the ongoing discourse in hematological research. Researchers are encouraged to contribute to this essential resource for the scientific community, contributing to the advancement of knowledge that ultimately improves patient care and treatment outcomes.